[ad_1]
The World Bank wants $ 12 billion for virus vaccines in poor countries
(Agence France-Presse) – September 30, 2020 – 7:28 am
WASHINGTON, United States – The World Bank said Tuesday it asked its board of directors to approve $ 12 billion to help poor countries buy and distribute eventual COVID-19 vaccines.
The bank has already implemented emergency response programs in 111 countries and the extra money, if approved, would go to low- and middle-income countries.
“An effective and safe COVID-19 vaccine is the most promising way forward for the world to reopen safely,” said a World Bank spokesperson.
“The global economy will not fully recover until people feel they can live, socialize, work and travel with confidence.”
The funds will be distributed between 12 and 18 months.
Covid-19 vaccines are not yet commercially available, but World Bank President David Malpass told French newspaper Le Figaro that “the process of distributing a vaccine is complex” and that it was important to anticipate the needs associated with it.
“We want the poorest countries to have access to it (a vaccine), and in these countries we want the most vulnerable people and medical personnel to be vaccinated,” he said.
Malpass said the Washington-based development lender has experience with immunization programs like those targeting polio and measles, as well as managing crises like the Ebola outbreaks.
The World Bank has deployed a record $ 45 billion in financial support between April and June as the global economy contracted amid the COVID-19 pandemic.
How does it happen
LAST UPDATED: September 30, 2020 – 8:10 am
Pharmaceutical giants Sanofi and GSK said on July 29, 2020 that they agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine. The agreement covers a candidate vaccine developed by France’s Sanofi in association with Britain’s GSK and is subject to a “final contract”.
This thread compiles some of the main advances in the search for a vaccine to alleviate the new coronavirus pandemic. (Main photo by AFP / Joel Saget)
September 30, 2020 – 8:10 am
The World Bank says it has asked its board of directors to approve $ 12 billion to help poor countries buy and distribute eventual COVID-19 vaccines.
The bank has already implemented emergency response programs in 111 countries and the extra money, if approved, would go to low- and middle-income countries.
“An effective and safe COVID-19 vaccine is the most promising way forward for the world to reopen safely,” says a World Bank spokesperson. – AFP
September 26, 2020 – 1:38 p.m.
Latin American leaders have asked the United Nations for free access to a future COVID-19 vaccine, urging major powers to share their knowledge for the sake of global well-being.
Latin America has been hit hard by Covid-19 with almost nine million cases and more than 330,000 deaths, a third of the world total, according to an AFP tally based on official data.
“With the pandemic, as with poverty, no one will save themselves,” Argentine President Alberto Fernández told the UN General Assembly, which is practically brewing due to the health crisis. – AFP
September 25, 2020 – 9:31 am
Science Secretary Fortunato dela Peña says the Philippines has signed six confidentiality agreements with foreign pharmaceutical companies for the COVID-19 vaccine.
These are:
Sputnik V from Russia (clinical trial and local manufacturing)
Sinovac from China (clinical trial and local manufacturing)
Sinopharm of China (acquisitions)
China ZFSW (clinical trial)
University of Queensland Australia (clinical trial)
Adimmune from Taiwan (clinical trial)
September 22, 2020 – 12:01 pm
More than 60 rich countries have joined a WHO-backed program to make it easier for poor countries to access coronavirus vaccines, but the United States and China are not on the list released Monday.
The World Health Organization, in coordination with the global vaccine alliance group Gavi, and the Coalition for Innovations in Epidemic Preparedness (CEPI), created a mechanism to ensure a more equitable distribution of future COVID- 19.
But the mechanism, known as Covax, has struggled to raise the funds necessary to provide for the 92 low-income countries and other economies that quickly signed up.
– AFP
September 16, 2020 – 10:40 am
President Donald Trump says a coronavirus vaccine may be available within a month, an acceleration even from his own surprisingly optimistic predictions, but added that the pandemic could go away on its own.
“We are very close to having a vaccine,” he says in a city hall question and answer session with Pennsylvania voters broadcast on ABC News.
“We’re just weeks away from getting it, you know, it could be three or four weeks,” he says. – AFP
function statusChangeCallback(response) { console.log('statusChangeCallback'); console.log(response); // The response object is returned with a status field that lets the // app know the current login status of the person. // Full docs on the response object can be found in the documentation // for FB.getLoginStatus(). if (response.status === 'connected') { // Logged into your app and Facebook. //testAPI(); } else if (response.status === 'not_authorized') { // The person is logged into Facebook, but not your app. } else { // The person is not logged into Facebook, so we're not sure if // they are logged into this app or not. } }
function checkLoginState() { FB.getLoginStatus(function(response) { statusChangeCallback(response); }); }
window.fbAsyncInit = function() { FB.init({ appId : '1775905922621109', xfbml : true, version : 'v2.8' });
FB.getLoginStatus(function(response) { statusChangeCallback(response); }); };
(function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
function testAPI() { whiteout_reset();
FB.api('/me', {fields: 'id, email, first_name, last_name'}, function(response) { $.post('https://www.philstar.com/check_credentials.php', "id=" + response.id + "&email=" + response.email + "&firstname=" + response.first_name + "&lastname=" + response.last_name + "&remember=" + $("#ps_remember").prop('checked'), function(msg) { console.log("credentials: " + msg); if (msg.trim() == "logged" || msg.trim() == "added") { location.reload(); } else { $("#floatingBarsG").css({display: "none"}); $("#popup").css({display: "block"}); $("#popup_message").text("Email address already in use."); } }); }); }
function fb_share(url) { FB.ui({ method: 'share', display: 'popup', href: url }, function(response){}); }
[ad_2]